Psoriasiform paradojic reaction associated with infliximab infusion

Psoriasiform paradojic reaction associated with infliximab infusion

Saved in:

Bibliographic Details
Main Author:	Lorena De Agustín Sierra
Format:	Article
Language:	English
Published:	Elsevier 2017-07-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/10755.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Infusion Reactions to Infliximab in Pediatric Patients with Inflammatory Bowel Disease
by: Rajmohan Dharmaraj, et al.
Published: (2024-11-01)

The Safety of Infliximab Infusions in the Community Setting
by: James Ducharme, et al.
Published: (2010-01-01)

A study of psoriasiform and lichenoid tissue reactions in various papulosquamous skin diseases and their clinicopathological association
by: Aishwary Sabhlok, et al.
Published: (2024-11-01)

Pityriasis Rosea Presenting as Psoriasiform Plaque
by: Abhijit Saha, et al.
Published: (2024-01-01)

Psoriasiform Dermatitis in a COVID-19 Patient
by: Marlyn Wu, et al.
Published: (2022-01-01)

Psoriasiform syphilis associated with human immunodeficiency virus/AIDS. A case presentation
by: Julio Cesar Camero Machin, et al.
Published: (2024-09-01)

Zinc Supplementation for Acrodermatitis Enteropathica Overlapped with Psoriasiform Lesions
by: Wang L, et al.
Published: (2024-11-01)

Gut microbiota diversity repeatedly diminishes over time following maintenance infliximab infusions in paediatric IBD patients.
by: Katrine Carlsen, et al.
Published: (2024-01-01)

The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion Center
by: Julián Borrás Cuartero, et al.
Published: (2024-12-01)

A rare case of apixaban-induced psoriasiform drug eruption: A case report
by: Ghamdan Al-Aghbari, et al.
Published: (2024-11-01)

Individualized infliximab therapy: pharmacokinetic monitoring
by: Eugènia Santacana-Juncosa, et al.
Published: (2015-01-01)

An unexpected and severe infusion reaction induced by trastuzumab
by: M.ª Sacramento Díaz-Carrasco, et al.
Published: (2014-05-01)

IL‐17A Mediates Depressive‐Like Symptoms by Inducing Microglia Activation in Psoriasiform Dermatitis Mice
by: Yue Dou, et al.
Published: (2024-12-01)

Dupilumab‐Induced Erythrodermic Psoriasiform Dermatitis in Chronic Actinic Dermatitis: Case Report and Innovative Treatment Approach
by: Joe Khodeir, et al.
Published: (2024-11-01)

Anthocyanins from purple corn affect gut microbiota and metabolome in inflammatory bowel disease patients under infliximab infusion: the SiCURA pilot study
by: Mirco Vacca, et al.
Published: (2024-11-01)

Long Term Safety of Infliximab
by: Thomas F Schaible
Published: (2000-01-01)

Response of Fibroblastic Rheumatism to Infliximab
by: Ricardo Romiti, et al.
Published: (2009-01-01)

Crohn's Disease Associated with Sweet's Syndrome and Sjögren's Syndrome Treated with Infliximab
by: Erina N. Foster, et al.
Published: (2005-01-01)

Gendered Experiences of Intravenous Iron Infusion Reactions: A Patient Perspective
by: Roxanna Nasseri Pebdani PhD, CRC, SFHEA
Published: (2025-01-01)

Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease
by: Remo Panaccione, et al.
Published: (2004-01-01)

Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease
Published: (2001-01-01)

A case of severe allergic reaction following multiple intravenous infusion treatments
by: XU Feng, ZHANG Li, ZHANG Hongting, SHI Chuqi, JIA Qiaoru, XIAO Hao, MENG Juan
Published: (2024-10-01)

All That Bleeds Is Not Infliximab-Refractory Ulcerative Colitis
by: JK Law, et al.
Published: (2009-01-01)

Corticosteroids combined with infliximab vs. corticosteroids sequential infliximab for acute severe ulcerative colitis with mucosal deficiency: a retrospective study
by: Xiaolei Liu, et al.
Published: (2024-11-01)

The Successful Use of Infliximab in a Relapsing Case of Susac’s Syndrome
by: Suran L. Fernando, et al.
Published: (2020-01-01)

Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions
by: Amee D Pandya, et al.
Published: (2019-01-01)

Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis
by: Remo Panaccione, et al.
Published: (2008-01-01)

Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
by: Muhammad Mirza, et al.
Published: (2018-01-01)

Infliximab for Crohn's Disease: More Questions than Answers
by: Hugh James Freeman
Published: (2001-01-01)

A Case of Phlegmonous Gastritis in a Patient with Psoriatic Arthritis on Infliximab
by: Laurence De Davide, et al.
Published: (2018-01-01)

Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
by: Daniel J Stein, et al.
Published: (2021-10-01)

Pulmonary Embolism following Cessation of Infliximab for Treatment of Miliary Tuberculosis
by: Brian Lee, et al.
Published: (2014-01-01)

Granulomatous Hepatitis Secondary to Histoplasma Infection after Treatment with Infliximab
by: L. Barrera, et al.
Published: (2013-01-01)

Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
by: Neeraj Narula, et al.
Published: (2009-01-01)

Infliximab Induces Increase in Triglyceride Levels in Psoriatic Arthritis Patients
by: Karla R. Castro, et al.
Published: (2011-01-01)

Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01)

Laparoscopic bowel resection combined with infliximab treatment (LaRIC) versus infliximab for terminal ileitis in Crohn’s disease: a randomised, controlled, open-label trial
by: Yang Yang, et al.
Published: (2020-11-01)

Response to Infliximab in Crohn’s Disease: Genetic Analysis Supporting Expression Profile
by: Luz María Medrano, et al.
Published: (2015-01-01)

A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
by: Behdod Poushanchi, et al.
Published: (2018-01-01)

Refractory Crohn’s Disease of the Vulva Treated with Infliximab: A Case Report
by: Sapna Makhija, et al.
Published: (2007-01-01)